Physician
Hemmer, Patrick
Hemmer, Patrick was paid $5.02M by Medicaid between Jan 2018 and Nov 2024, across 198 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 22% of everything it billed.
33Billing provider infoHEMMER, PATRICK
SPRINGFIELD, IL 62769
SPRINGFIELD, IL 62769
33aNPI1215908850assigned 01/31/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$5.02M
24GClaims613,735
24DCodes billed198
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#9 of 398
Median peer was paid$66K
This provider vs. median76×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 57,701 | $343K | |
| 2019 | 81,946 | $505K | |
| 2020 | 96,986 | $661K | |
| 2021 | 85,739 | $826K | |
| 2022 | 155,153 | $1.59M | |
| 2023 | 53,607 | $424K | |
| 2024incomplete | 82,603 | $671K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 22% | 6,501 | 5,794 | $1.11M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.4% | 9,137 | 6,895 | $273K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.8% | 3,891 | 3,476 | $191K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3.6% | 4,399 | 3,931 | $180K |
| 80053 | Comprehensive metabolic panel | 3.6% | 35,224 | 20,886 | $180K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.3% | 58,388 | 33,107 | $168K |
| 87486 | 3.2% | 7,261 | 6,503 | $162K | |
| 87581 | 3.2% | 7,255 | 6,501 | $162K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.1% | 4,289 | 3,381 | $155K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.8% | 34,064 | 16,524 | $141K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.4% | 5,683 | 5,243 | $122K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.4% | 5,663 | 5,228 | $122K |
186 more codes
| 82805 | 2.0% | 3,695 | $102K | |
| 82948 | 1.8% | 32,297 | $91K | |
| 83735 | 1.6% | 23,376 | $80K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.6% | 15,394 | $78K |
| 87040 | 1.5% | 6,863 | $74K | |
| 82803 | 1.5% | 6,988 | $73K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.4% | 1,684 | $69K |
| 82330 | 1.2% | 6,802 | $59K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 7,226 | $59K |
| 87480 | 1.0% | 4,438 | $52K | |
| 87510 | 1.0% | 4,325 | $50K | |
| 84484 | <1% | 11,281 | $50K | |
| 87641 | <1% | 2,128 | $47K | |
| 83880 | <1% | 4,317 | $46K | |
| 87507 | <1% | 265 | $44K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,254 | $44K |
| 85027 | <1% | 14,224 | $41K | |
| 83605 | <1% | 7,114 | $38K | |
| 88307 | <1% | 643 | $38K | |
| 87660 | <1% | 4,545 | $35K | |
| 83690 | <1% | 10,420 | $35K | |
| 87653 | <1% | 1,527 | $34K | |
| 84702 | <1% | 7,370 | $33K | |
| 87797 | <1% | 2,481 | $31K | |
| 86901 | <1% | 12,257 | $30K | |
| 86850 | <1% | 10,099 | $29K | |
| 87186 | <1% | 4,649 | $27K | |
| 85610 | <1% | 13,326 | $27K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,740 | $26K |
| 84100 | <1% | 12,062 | $26K | |
| 81001 | <1% | 19,686 | $26K | |
| 86900 | <1% | 12,267 | $23K | |
| 85730 | <1% | 6,728 | $23K | |
| 87430 | <1% | 2,627 | $20K | |
| 80202 | <1% | 2,756 | $18K | |
| 80076 | <1% | 5,042 | $18K | |
| 86803 | <1% | 2,142 | $17K | |
| 85379 | <1% | 3,798 | $15K | |
| 82248 | <1% | 6,966 | $14K | |
| 81025 | <1% | 6,316 | $13K | |
| 82247 | <1% | 6,532 | $13K | |
| 85007 | <1% | 7,306 | $12K | |
| 86140 | <1% | 4,580 | $11K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 743 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,258 | $10K |
| 87340 | <1% | 1,570 | $10K | |
| 82550 | <1% | 3,202 | $10K | |
| 80061 | Lipid panel | <1% | 2,880 | $10K |
| 83615 | <1% | 3,382 | $9K | |
| 87070 | <1% | 2,866 | $9K | |
| 80074 | <1% | 445 | $8K | |
| 84439 | <1% | 1,918 | $8K | |
| 87205 | <1% | 3,962 | $8K | |
| 82565 | <1% | 3,881 | $8K | |
| 82728 | <1% | 1,942 | $8K | |
| 86880 | <1% | 2,633 | $8K | |
| 84295 | <1% | 3,643 | $8K | |
| 85014 | <1% | 6,131 | $7K | |
| 87081 | <1% | 2,366 | $7K | |
| 84132 | <1% | 3,692 | $7K | |
| 86592 | <1% | 3,268 | $6K | |
| 82140 | <1% | 1,456 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 765 | $6K |
| 85520 | <1% | 1,233 | $6K | |
| 84460 | <1% | 2,540 | $6K | |
| 86780 | <1% | 776 | $6K | |
| 84550 | <1% | 2,812 | $6K | |
| 84450 | <1% | 2,526 | $5K | |
| 87088 | <1% | 921 | $5K | |
| 82607 | <1% | 814 | $5K | |
| 80069 | <1% | 1,128 | $5K | |
| 86762 | <1% | 1,141 | $5K | |
| 87483 | <1% | 28 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 225 | $5K |
| 83550 | <1% | 1,175 | $4K | |
| 83540 | <1% | 1,382 | $4K | |
| 87075 | <1% | 584 | $4K | |
| 82570 | <1% | 1,831 | $4K | |
| 85046 | <1% | 1,576 | $4K | |
| 87184 | <1% | 833 | $4K | |
| 85384 | <1% | 1,215 | $4K | |
| 82553 | <1% | 811 | $4K | |
| 85652 | <1% | 2,705 | $4K | |
| 82784 | <1% | 512 | $4K | |
| 82010 | <1% | 1,399 | $3K | |
| 80051 | <1% | 1,214 | $3K | |
| 86870 | <1% | 433 | $3K | |
| 87015 | <1% | 775 | $3K | |
| 86038 | <1% | 399 | $3K | |
| 82150 | <1% | 906 | $3K | |
| 87400 | <1% | 341 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 201 | $3K |
| 85018 | <1% | 2,540 | $3K | |
| 87147 | <1% | 1,197 | $3K | |
| 86922 | <1% | 217 | $2K | |
| 87077 | <1% | 1,620 | $2K | |
| 83021 | <1% | 412 | $2K | |
| 87449 | <1% | 291 | $2K | |
| 86225 | <1% | 388 | $2K | |
| 82310 | <1% | 1,259 | $2K | |
| 86480 | <1% | 85 | $2K | |
| 80081 | <1% | 72 | $2K | |
| 80306 | <1% | 356 | $2K | |
| 82746 | <1% | 351 | $2K | |
| 83516 | <1% | 304 | $2K | |
| 87420 | <1% | 242 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 84 | $2K |
| 84520 | <1% | 1,202 | $2K | |
| 89051 | <1% | 579 | $2K | |
| 84156 | <1% | 1,636 | $2K | |
| 87493 | <1% | 85 | $2K | |
| 81003 | <1% | 1,570 | $2K | |
| 84146 | <1% | 238 | $2K | |
| 86787 | <1% | 217 | $2K | |
| 82962 | <1% | 741 | $1K | |
| 86706 | <1% | 213 | $1K | |
| 83970 | <1% | 89 | $1K | |
| 86920 | <1% | 288 | $1K | |
| 87102 | <1% | 370 | $1K | |
| 83655 | <1% | 213 | $1K | |
| 82105 | <1% | 162 | $1K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 120 | $1K |
| 84481 | <1% | 231 | $1K | |
| 81329 | <1% | 32 | $1K | |
| 82533 | <1% | 128 | $996.99 | |
| 86003 | <1% | 56 | $995.50 | |
| 84466 | <1% | 216 | $920.22 | |
| 87116 | <1% | 126 | $889.20 | |
| 84703 | <1% | 250 | $885.74 | |
| 87324 | <1% | 116 | $879.20 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 22 | $861.98 |
| 87522 | Neg quan hep c or qual rna | <1% | 30 | $830.08 |
| 84478 | <1% | 355 | $815.76 | |
| 82785 | <1% | 168 | $761.61 | |
| 87206 | <1% | 267 | $755.88 | |
| 85347 | <1% | 246 | $693.32 | |
| 88304 | <1% | 39 | $653.74 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 79 | $609.15 |
| 84300 | <1% | 286 | $606.32 | |
| 83930 | <1% | 202 | $577.84 | |
| 83001 | <1% | 66 | $568.53 | |
| 82945 | <1% | 344 | $535.80 | |
| 80164 | <1% | 117 | $522.34 | |
| 86704 | <1% | 67 | $499.60 | |
| 82657 | <1% | 28 | $485.45 | |
| 87807 | <1% | 95 | $457.73 | |
| 87254 | <1% | 72 | $457.60 | |
| 84157 | <1% | 352 | $426.31 | |
| 85049 | <1% | 520 | $356.57 | |
| 87181 | <1% | 27 | $356.50 | |
| 82375 | <1% | 91 | $352.05 | |
| 82947 | <1% | 225 | $334.19 | |
| 86698 | <1% | 15 | $334.15 | |
| 88342 | <1% | 31 | $300.45 | |
| 87450 | <1% | 42 | $284.25 | |
| 83050 | <1% | 105 | $272.22 | |
| 84075 | <1% | 179 | $266.68 | |
| 84403 | <1% | 20 | $252.80 | |
| 84145 | <1% | 87 | $228.62 | |
| 84155 | <1% | 217 | $224.42 | |
| 86665 | <1% | 14 | $218.00 | |
| 84030 | <1% | 74 | $194.62 | |
| 83002 | <1% | 35 | $178.19 | |
| 82043 | <1% | 92 | $177.30 | |
| 82950 | <1% | 76 | $177.08 | |
| 83935 | <1% | 75 | $170.09 | |
| 80177 | <1% | 31 | $149.05 | |
| 84402 | <1% | 14 | $128.38 | |
| 87176 | <1% | 28 | $119.35 | |
| 86885 | <1% | 37 | $115.90 | |
| 87899 | <1% | 13 | $113.64 | |
| 82139 | <1% | 18 | $104.58 | |
| 84305 | <1% | 15 | $101.87 | |
| 85660 | <1% | 36 | $90.87 | |
| 86308 | <1% | 37 | $86.40 | |
| 85461 | <1% | 28 | $77.45 | |
| 86431 | <1% | 18 | $65.16 | |
| 84134 | <1% | 14 | $61.32 | |
| 82436 | <1% | 19 | $39.61 | |
| 82042 | <1% | 14 | $34.95 | |
| 84133 | <1% | 19 | $33.60 | |
| 82977 | <1% | 14 | $32.40 | |
| 86593 | <1% | 14 | $28.00 | |
| 81002 | <1% | 13 | $16.90 | |
| 86923 | 0% | 464 | $0.00 | |
| 87150 | 0% | 103 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.